RA & Gout - MOA Flashcards
Abatacept
inhibit T cell activation; induce T cell apoptosis
Certolizumab
block binding of TNF to TNF-receptor
Rituximab
anti-CD20 monoclonal Ab, decreases circulating B cells
Golimumab
block binding of TNF to TNF-receptor
Anakinra
IL-1 receptor antagonist
Etanercept
block binding of TNF to TNF-receptor
Tocilizumab
IL-6 receptor antagonist
Infliximab
block binding of TNF to TNF-receptor
Indomethacin
eliminates pain and inflammation; no effect on disease progression
Adalimumab
block binding of TNF to TNF-receptor
Naproxen
eliminates pain and inflammation; no effect on disease progression
COX-2 inhibitors
eliminates pain and inflammation; no effect on disease progression
Febuxostat
Xanthine Oxidase antagonist
Allopurinol
- decrease UA synthesis by competitively inhibiting XO
2. its metabolite, Alloxanthine, is a non-competitive inhibitor of XO
Colchicine
prevent tubulin polymerization, leading to inhibition of leukocyte migration, phagocytosis, and cytokine release
Glucocorticoids
- inhibit PLA2 and function of prostaglandins
2. inhibit cytokine production and prevent COX-2 induction
Quinolones
reduce T cell activation and chemotaxis
Gold Salts
anti-pruritic; repress immune responsiveness by inhibiting functional capacity of macrophages
Sulfasalazine
inhibit release of IL-1, TNF-alpha
Methotrexate
- inhibit AICAR transformylase and thymidylate synthetase, with effects on PMN chemotaxis
- cause increased adenosine to inhibit inflammataion
Leflunomide
inhibit DHODH to inhibit T-lymphocyte response
Pegloticase
convert UA to allantoin
Probenecid
compete with urate at the anionic transport site of renal tubule, thus inhibiting urate reabsorption